Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-29
2007-05-29
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S424000, C549S425000
Reexamination Certificate
active
10494260
ABSTRACT:
The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2is acetyl or trifluoroacetyl; X is CONH, NHCO or O; n is an integer from 2 to 6; and Y is C2–C8alkyl C3-8cycloalkyl, C1–C4alkoxyalkyl, an amino acid or dipeptide, or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection
REFERENCES:
patent: 6548476 (2003-04-01), Wu et al.
patent: WO 98/21243 (1998-05-01), None
patent: WO 00/55149 (2000-09-01), None
patent: WO 02/20514 (2002-03-01), None
Fleming, DM ‘Managing influenza: amantadine, rimantadine and beyond’ PMID: 11351773, (2001).
Supplementary European Search Report of EP 02 77 1913.
Jin Betty
MacDonald Simon J. F.
McConnell Darryl
Nguyen Van T. T.
Shanahan Stephen E.
Biota Scientific Management Pty Ltd.
Foley & Lardner LLP
Owens Amelia A.
LandOfFree
Dimeric compounds and their use as anti-viral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dimeric compounds and their use as anti-viral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimeric compounds and their use as anti-viral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3809185